选定的血液炎症标志物联合影像学特征能否预测胶质瘤患者的增殖指数
本研究回顾性纳入183例原发性胶质瘤患者,分析术前外周血中性粒细胞淋巴细胞比值(NLR)、单核细胞淋巴细胞比值、血小板淋巴细胞比值(PLR)及影像学特征与Ki-67增殖指数的关系。结果显示NLR和PLR在高级别胶质瘤组显著高于低级别胶质瘤组,年龄>43岁、NLR>3.68和强化阳性独立预测更高的增殖率,NLR和强化与胶质瘤增殖潜能正相关。
要点
- Ki-67截断值>9%可预测高级别胶质瘤。
- 高级别胶质瘤组平均NLR和PLR显著高于低级别胶质瘤组(P<0.01)。
- 年龄>43岁、NLR>3.68和强化阳性独立预测更高的增殖率。
核心结论
- NLR和强化与胶质瘤的增殖潜能呈正相关。
研究设计与样本
- 本研究为回顾性研究,纳入183例原发性诊断的胶质瘤患者,复习临床特征、术前外周血全血细胞计数数据和脑磁共振成像表现,并通过免疫组化染色测定Ki-67增殖指数。
主要发现
- 增殖指数与肿瘤级别高度相关,呈逐渐升高趋势。
- Ki-67截断值>9%可预测高级别胶质瘤。
- 高级别胶质瘤组平均NLR和PLR显著高于低级别胶质瘤组(NLR:3.11 ± 0.59 vs. 4.27 ± 1.13;PLR:133.07 ± 13.17 vs. 161.51 ± 38.99;两者P < 0.01)。
- 高级别胶质瘤组更可能出现强化,但两组间瘤周水肿无显著差异。
- 逻辑回归分析识别出预测增殖潜能的危险因素包括年龄、卡氏功能评分、NLR、PLR和强化;其中年龄>43岁、NLR>3.68和强化阳性独立预测更高的增殖率。
关键数值与推荐
- Ki-67截断值>9%预测高级别胶质瘤。
- 年龄>43岁、NLR>3.68和强化阳性独立预测更高的增殖率。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The tumor microenvironment is partially characterized by a state of chronic inflammation, and radiologic features are related to the tumor's biological behavior. This study was conducted to explore whether peripheral blood inflammatory markers combined with radiologic features could predict proliferation potency. METHODS: This study retrospectively reviewed 183 patients with a primary diagnosis of glioma. Clinical characteristics, preoperative peripheral full blood count data, and brain magnetic resonance imaging findings were reviewed to analyze the expression of inflammatory markers neutrophil lymphocyte ratio (NLR), monocyte lymphocyte ratio, and platelet lymphocyte ratio (PLR), as well as radiologic features such as location, peritumor edema, and contrast enhancement. Immunohistochemical staining was performed to determine the proliferation index (i.e., expression of Ki-67). Receiver operating characteristic curves for cutoff value, various bivariate tests, and binary logistic regression analyses were applied. RESULTS: Proliferation index was highly associated with tumor grade, showing a gradually increasing tendency. A Ki-67 cutoff value >9% predicted high-grade glioma (HGG). Mean NLR and PLR were significantly higher in the HGG group compared with the low-grade glioma group (NLR: 3.11 ± 0.59 vs. 4.27 ± 1.13; PLR: 133.07 ± 13.17 vs. 161.51 ± 38.99; P < 0.01 for both). Contrast enhancement was more likely in the HGG group, but there was no significant between-group difference in peritumor edema. Logistic regression analysis identified the following risk factors for prediction of proliferation potency: age, Karnofsky Performance Score, NLR, PLR, and contrast enhancement. However, age >43 years, NLR >3.68, and positive contrast enhancement independently predicted a higher proliferation rate. CONCLUSIONS: NLR and contrast enhancement were positively correlated with the proliferation potency of gliomas.
引用
- Weng Y, Zhang X, Han J, et al. Do Selected Blood Inflammatory Markers Combined with Radiological Features Predict Proliferation Index in Glioma Patients? World Neurosurg. 2018. PMID: 29959082. doi:10.1016/j.wneu.2018.06.142
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。